The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Comparison of ciprofloxacin hydrochloride‐loaded protein, lipid, and chitosan nanoparticles for drug delivery
Abstract
The aim of the present study was to develop single dose delivery systems based on nanotechnology for prolonged antibiotic release in a controlled manner. Five different drug–carrier ratios of ciprofloxacin hydrochloride‐loaded nanoparticles of albumin, gelatin, chitosan (CS), and lipid [solid lipid nanoparticles (SLNs)] were prepared and characterized. Average particle size was found to be in the range of 73 ± 2 to 98 ± 44 nm for SLNs, 140 ± 7 to 175 ± 24 nm for albumin nanoparticles, 143 ± 18 to 184 ± 27 nm for gelatin nanoparticles, and 247 ± 48 to 322 ± 52 nm for CS nanoparticles. A drug‐to‐carrier ratio of 0.5:1 was preferred for CS nanoparticles having zeta potential of >20 mV and drug encapsulation of 35.01% ± 2.66%. Similarly, 0.6:1 ratio was preferred for albumin nanoparticles with zeta potential >16 mV and drug encapsulation 48.20% ± 3.01%. Zeta potentials of gelatin nanoparticles loaded with ciprofloxacin suggested that they were unstable and prone to flocculation. SLN with 0.25:1 drug carrier ratio showed 38.71% ± 2.38% drug entrapment and −28 ± 1 mV surface charge. All the nanoparticles showed sustained drug release avoiding “burst effect” of the free drugs for up to 120 h for albumin nanoparticles, 96 h for CS and gelatin nanoparticles, and 80 h for SLNs. The drug release profiles followed Higuchi model. Results suggest that CS nanoparticles and SLNs can act as promising carriers for sustained ciprofloxacin release in infective conditions. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2008
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Jain et al. used different nanocarriers for ciprofloxacin encapsulation and showed that SLNs were able to promote a prolonged drug release.215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“Apart from ciprofloxacin, SLNs were also capable of loading other anti-TB drugs, such as rifabutin, INH, RIF, and PZA.215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“Jain and Banerjee also demonstrated the sustained release of ciprofloxacin (up to 80 h).215”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
In the citing paper
“SLNs have been extensively used in formulations for the delivery of anti-TB drugs.”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [215]
Citations
Cites
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,494
Optimization of the preparation process for human serum albumin (HSA) nanoparticles
Langer, K., Balthasar, S., Vogel, V., Dinauer, N., von Briesen, H., & Schubert, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00134-0 · Cited by 760
Desolvation process and surface characterisation of protein nanoparticles
Weber, C., Coester, C., Kreuter, J., & Langer, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00370-1 · Cited by 605
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Preparation and characterization of chitosan microparticles intended for controlled drug delivery
Ko, J. A., Park, H. J., Hwang, S., Park, J. B., & Lee, J. S. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00487-8 · Cited by 462
Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles
Banerjee, T., Mitra, S., Singh, A. K., Sharma, R. K., & Maitra, A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00267-3 · Cited by 409
Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration
Wissing, S. A., & Müller, R. H. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00056-1 · Cited by 405
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 368
Nanomedicines for overcoming biological barriers
Alonso, M. J. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Flagged first, then by citations
Research works printed but not linked: 2
- Coester C, 2006, In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localization, Eur J Pharm Sci, 62, 306
- Utreja S, 2001, Advances in Controlled and Novel Drug Delivery, 408
Cited by
Sorted by citations
Items 101–158 of 158
Polysaccharide‐based electroconductive films for controlled release of ciprofloxacin
Aycan, D., Dolapçı, N., Karaca, Ö. G., & Alemdar, N. (2022) · Journal of Applied Polymer Science · doi:10.1002/app.52761 · Cited by 12
Nanoparticles for Endodontic Disinfection
Kishen, A., & Shrestha, A. (2015) · Springer eBooks · doi:10.1007/978-3-319-13575-5_6 · Cited by 12
Nanosized devices as antibiotics and antifungals delivery: past, news, and outlook
Furneri, P. M., Petronio, G. P., Fuochi, V., Cupri, S., & Pignatello, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00023-3 · Cited by 13
Solid Lipid Nanoparticles as Drug Delivery System for Water-Insoluble Drugs
Li, R., Lim, S., Choi, H.-G., & Lee, M.-K. (2010) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2010.40.s.063 · Cited by 11
Modified rifampin nanoparticles: Increased solubility with slow release Rate
Ghanavi, J., Farnia, P., Velayati, A. A., & Mollaei, S. (2017) · International Journal of Mycobacteriology · doi:10.4103/ijmy.ijmy_21_17 · Cited by 11
Güncüm, E., Işıklan, N., Anlaş, C., Bulut, E., & Bakırel, T. (2023) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2023.2179269 · Cited by 10
Le‐Deygen, I. M., Safronova, A. S., Mamaeva, P. V., Khristidis, Y. I., Kolmogorov, I. M., Скуредина, А. А., Timashev, P. S., & Kudryashova, E. V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041101 · Cited by 10
Nanostructures as Antimicrobial Therapeutics
Kulshreshtha, N. M., Jadhav, I., Dixit, M., Sinha, N., Shrivastava, D., & Bisen, P. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52733-0.00002-1 · Cited by 10
Bio-Based Nanoemulsions: An Eco-Safe Approach Towards the Eco-Toxicity Problem
Mishra, P., Balaji, A. P. B., Mukherjee, A., & Chandrasekaran, N. (2018) · Springer eBooks · doi:10.1007/978-3-319-48281-1_94-1 · Cited by 10
Mohamed, S. A., Mahmoud, H. E., Embaby, A. M., Haroun, M., & Sabra, S. A. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129842 · Cited by 9
Nanoparticle-Based Drug Delivery Systems: Promising Approaches Against Bacterial Infections
Rai, A., Comune, M., & Ferreira, L. (2019) · Springer eBooks · doi:10.1007/978-981-13-9871-1_27 · Cited by 9
David, K. I., Ravikumar, T., Sethuraman, S., & Krishnan, U. M. (2021) · Biomedical Materials · doi:10.1088/1748-605x/ac177c · Cited by 9
Zhuang, H., Xu, Y., Zheng, H., Huan, Y.-R., Zheng, N.-X., Lin, L., Zhang, W.-Z., & Xu, W. (2021) · Arquivos Brasileiros de Oftalmologia · doi:10.5935/0004-2749.20220075 · Cited by 9
Matalqah, S. M., Aiedeh, K., Mhaidat, N. M., Alzoubi, K. H., & Al-Husein, B. A. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220126100532 · Cited by 9
Nanostructure Drug Delivery System Is an Option to Solve Antimicrobial Drug Resistance
Patil, J., Dhadde, S. B., & Chandakavathe, B. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814031-4.00007-6 · Cited by 9
Abdel-Rashid, R. S., El-Leithy, E. S., & Abdel-moneum, R. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02189-2 · Cited by 8
Application of Nanotechnology in Immunity against Infection
Zhang, J., Shi, W., Ma, Q., Cui, H., & Zhang, L. (2021) · Coatings · doi:10.3390/coatings11040430 · Cited by 7
Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatment
Carneiro, S. P., & dos Santos, O. D. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00012-6 · Cited by 7
Rodríguez, E. M., Gomez‐Mendoza, M., Pérez–Ruíz, R., Peñín, B., Sampedro, D., Caamaño, A. J., & O’Shea, V. A. D. L. P. (2021) · Biomedicines · doi:10.3390/biomedicines9121953 · Cited by 6
Wang, B., Su, Z., Kuang, M., Luo, Y., Xu, M., Sun, M., Liu, X., Guo, Y., Bai, L., Wang, Y., et al. (2025) · Biomedical Materials · doi:10.1088/1748-605x/adb2cf · Cited by 6
Sarkar, T., Singh, M., Jana, B. K., & Mazumder, B. (2023) · Letters in Drug Design & Discovery · doi:10.2174/1570180820666230509095446 · Cited by 7
Birk, S. E., Serioli, L., Cavallo, V., Haagensen, J. A. J., Molin, S., Nielsen, L. H., Zór, K., & Boisen, A. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100150 · Cited by 6
Ali, M. N., Al‐Saadi, T. M., & Al-Faragi, J. K. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1879/3/032075 · Cited by 6
Mailafiya, M. M., Abubakar, K., Danmaigoro, A., Chiroma, S. M., Rahim, E. B. A., Moklas, M. A. M., & Zakaria, Z. A. B. (2019) · Preprints.org · doi:10.20944/preprints201908.0254.v1 · Cited by 5
Sánchez, S. V., Jorge, E. C., Martínez, N. M. N., González, M. J., Vásquez, R., Canto, F. D., Scavone, P., Arrúa, E. C., & Morales, J. O. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03115-6 · Cited by 5
Hanif, M., Khan, H. U., Afzal, S., Mahmood, A., Maheen, S., Afzal, K., Iqbal, N., Andleeb, M., & Abbas, N. (2017) · Acta Pharmaceutica · doi:10.1515/acph-2017-0034 · Cited by 4
Bio-based Nanoemulsions: An Eco-safe Approach Towards the Eco-toxicity Problem
Mishra, P., Balaji, A. P. B., Mukherjee, A., & Chandrasekaran, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-68255-6_94 · Cited by 4
Polysaccharides-Based Microcapsules
Jia, Y., Feng, X., & Li, J. (2017) · Springer eBooks · doi:10.1007/978-981-10-6059-5_4 · Cited by 4
Lipid-based nanoparticles as novel drug delivery systems for antimicrobial agents
Rassouli, A., & Al-Qushawi, A. (2018) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22067/veterinary.v2i10.75569 · Cited by 4
Amiri, S., Ghasemvand, F., Dini, G., & Vaezifar, S. (2024) · Emergent Materials · doi:10.1007/s42247-024-00765-3 · Cited by 3
Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
Dakkah, A. N., Bataineh, Y. A., Al-Jaidi, B. A., Bayan, M. F., & Nimer, N. A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_13 · Cited by 3
The Use of Nanoparticles for Antimicrobial Delivery
Moreno-Sastre, M., Pastor, M., Esquisabel, A., & Pedraz, J. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-28368-5_17 · Cited by 3
Chaurasia, V., Kumar, V. M., & Jain, D. (2016) · Bulletin of Pharmaceutical Research · doi:10.21276/bpr.2016.6.2.4 · Cited by 3
Self-citationNanotechnology Applications for Infectious Diseases
Tobin, E. H. (2013) · CRC Press eBooks · doi:10.1201/b15642-2 · Cited by 3
Development and Characterization of Nanocarrier Systems for the Delivery of Antitubercular Drugs
Ribeiro, R. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/b6v3-t472 · Cited by 3
Shi, S., Lü, W., Gu, X., & Lin, Q. (2024) · Microbial Drug Resistance · doi:10.1089/mdr.2023.0066 · Cited by 2
p, R., Prajapati, B. G., Rajeshkumar, R., Balasubramaniam, V., & Ponnusankar, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673314366240712105637 · Cited by 2
Esgueira, V. L. R., Lopes, C., dos Santos, A. C. A., Pinto, F., Sousa, S. A., de Barros, D. P. C., Leitão, J. H., & Fonseca, L. P. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-88071-2_3 · Cited by 2
Antibacterial and Drug Elution Performance of Thermoplastic Blends
Jones, A., Mandal, A., & Sharma, S. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-016-0924-y · Cited by 2
Chitosan based nanocarriers for delivery of therapeutic agents
Ogundolie, F. A., Babalola, O. O., Adebayo-Gege, G. I., Alabi, T. D., & Adetunji, C. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13997-0.00019-9 · Cited by 1
Lin, C., Chu, Y., Liu, F., & Wang, P. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115343 · Cited by 1
Castro, C. G., Duarte, K. E., dos Reis, R. A., Moreira, V. A., Lombello, R. A., Castro, J. C., Seabra, A. B., & Centeno, D. C. (2025) · Plant Nano Biology · doi:10.1016/j.plana.2025.100243 · Cited by 2
Nanotechnology Applications for Infectious Diseases
Tobin, E. H., & MD, M. (2013) · CRC Press eBooks · doi:10.1201/b15642-5 · Cited by 1
FORMULATION AND DEVELOPMENT OF FLUOXETINE TRANSDERMAL PATCHES: IN VITRO AND IN VIVO EVALUATION
Singh, D., & Chandra, A. (2016) · International Journal of Pharmaceutical Research and Innovation · doi:10.20530/ijpri_9_1-8 · Cited by 1
Preparation and Characterization of Biopolymeric Nanoparticles as Drug Delivery Vehicles
Sagiri, S. S., Nayak, S. K., Lakshmi, S., & Pal, K. (2017) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-5225-3023-7.ch010 · Cited by 1
Manuroop, T., Bharavi, K., Jahan, A., Raj, M. A., Kumar, P. A., & Rao, G. S. (2020) · The Pharma Innovation · doi:10.22271/tpi.2020.v9.i3b.4448 · Cited by 1
Cui, Y., Zhang, J., Liu, Y., Meng, G., & Lv, C. (2021) · Journal of Cluster Science · doi:10.1007/s10876-021-02159-5 · Cited by 1
Veterinary Nanomedicine Delivery System for Mastitis
Nanjwade, B. K. (2023) · Nanomedicine & Nanotechnology Open Access · doi:10.23880/nnoa-16000239 · Cited by 1
Polymeric micro- and nanoparticles for delivery of therapeutic peptides
Moutinho, L. C. P. D. S. P. (2010)
Removal of Arsenic Species through Coagulation-Flocculation Processes
Bhalkaran, S. (2017) · University Library - University of Saskatchewan (University of Saskatchewan)
Isa, T., Yakubu, S. I., Rukayadi, Y., & Jaji, A. Z. (2017) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Kotb, A., Ramadan, S., Hazzah, A., Khedr, I., & Abd-Elaziz, M. (2018) · The International Conference on Chemical and Environmental Engineering · doi:10.21608/iccee.2018.34665
Wang, T. (2019) · OpenCommons at University of Connecticut (University of Connecticut)
Carbohydrate Modified Non-Metallic Nanomaterials and Their Application Against Infectious Diseases
Mosaiab, T., Farr, D. C., Kiefel, M. J., & Houston, T. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00096-1
Fluoroquinolones Metal Complexes as Potent Antibacterial Agents
Khatri, S., Kumar, M., Sehrawat, H., Khatkar, S. P., Taxak, V. B., & Kumar, R. (2022) · Asian Journal of Chemistry · doi:10.14233/ajchem.2022.23600
Preparation and Characterization of Biopolymeric Nanoparticles as Drug Delivery Vehicles
Sagiri, S. S., Nayak, S. K., Lakshmi, S. M., & Pal, K. (2021) · IGI Global eBooks · doi:10.4018/978-1-7998-8591-7.ch069
Solid-Lipid Nanocarriers (SLNs)-Based Drug Delivery for Treating Various Pulmonary Diseases
Vyas, T., Gorantla, S., Waghule, T., Rapalli, V. K., & Singhvi, G. (2022) · Springer eBooks · doi:10.1007/978-981-16-4392-7_13
Metadata
- Authors
- Jain, D., & Banerjee, R.
- Affiliations
- Indian Institute of Technology Bombay (IN)
- Corresponding author
- Banerjee, R.
- Venue
- Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Publisher
- Wiley
- Published
- 2007-12-20
- Volume
- 86B
- Issue
- 1
- Pages
- 105-112
- ISSN
- 1552-4973 (ISSN-L)
- 1552-4981
- OpenAlex
- W2074420216
- Cited by
- 158
- References
- 34
- Citations by year
- 2025: 6 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 15 · 2018: 12 · 2017: 18 · 2016: 15 · 2015: 7 · 2014: 5 · 2013: 11 · 2012: 4
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biomedical Materials Research Part B Applied Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- DSpace (IIT Bombay) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- ciprofloxacin hydrochloride, chitosan nanoparticles, solid lipid nanoparticles, albumin nanoparticles, gelatin nanoparticles, sustained drug release, encapsulation efficiency, zeta potential, Higuchi model, burst release, nanoparticle stability
- MeSH terms
- Albumins, Animals, Cattle, Ciprofloxacin, Drug Carriers, Gelatin, Lipids, Particle Size, Polymers, Scattering, Radiation, Serum Albumin, Drug Delivery Systems, Nanotechnology, Chitosan, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
